Abiopharma

News list

Mehta Vikas D 🔴 sold 44.3K shares of Remitly Global, Inc. (RELY) at $26.59 ($1.2M) Transaction Date: Aug 25, 2026 | Filing ID: 000009

Full text

News bot Aug. 27, 2026, 12:01 a.m.
🔍 Mehta Vikas D (Executive)

Company: Remitly Global, Inc. (RELY)

Report Date: 2026-08-25
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 44,269
Detailed Transactions and Holdings:
- Sold 19,269 shares of Common Stock at $26.59 per share (Direct)
  Date: 2026-08-25 | Code: F | equity_swap_involved: 0 | shares_owned_after: 968,735.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 25,000 shares of Common Stock at $26.15 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 943,735.00 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
- F2: This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2025.
- F3: Weighted average price. These shares were sold in multiple transactions at prices ranging from $25.83 to $26.39 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.